GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » Pre-Tax Income

Q32 Bio (Q32 Bio) Pre-Tax Income : $-25.61 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Q32 Bio Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Q32 Bio's pretax income for the three months ended in Mar. 2024 was $1.21 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-25.61 Mil. Q32 Bio's pretax margin was %.

During the past 3 years, Q32 Bio's highest Pretax Margin was 803.26%. The lowest was -642.72%. And the median was 80.27%.


Q32 Bio Pre-Tax Income Historical Data

The historical data trend for Q32 Bio's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q32 Bio Pre-Tax Income Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23
Pre-Tax Income
-37.02 -42.75 -53.43

Q32 Bio Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial -9.67 -6.84 - -26.81 1.21

Competitive Comparison of Q32 Bio's Pre-Tax Income

For the Biotechnology subindustry, Q32 Bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q32 Bio's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Q32 Bio's Pre-Tax Income falls into.



Q32 Bio Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Q32 Bio's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-48.255+-5.17+0+0+7.105427357601E-15
=-53.43

Q32 Bio's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-14.843+16.048+0+0+1.7763568394003E-15
=1.21

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q32 Bio  (NAS:QTTB) Pre-Tax Income Explanation

Q32 Bio's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=1.205/0
=%

During the past 3 years, Q32 Bio's highest Pretax Margin was 803.26%. The lowest was -642.72%. And the median was 80.27%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q32 Bio Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Q32 Bio's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Q32 Bio (Q32 Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
830 Winter Street, Waltham, MA, USA, 02451
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Q32 Bio (Q32 Bio) Headlines

From GuruFocus